Remove Branding Remove Genome Remove Life Science
article thumbnail

Caprion Becomes CellCarta: CRO Rebrands After Banner Year for Acquisitions and Partnerships

XTalks

The move follows the 2019 merger between Caprion and HistoGeneX , a Belgian histopathology and genomics lab. We wanted to create a brand that is unique in the market, relevant to our clients and inspiring to our employees around the world,” said Nick Wright, president and COO of CellCarta, in a statement about the rebrand. “Our

article thumbnail

Fastest Growing Medical Device/Medtech Companies in 2024

XTalks

Exact Sciences (Overall Rank 281) Exact Sciences , founded in 1995, is a molecular diagnostics company specializing in early cancer screening and diagnostic tests. Exact Sciences is also investing in its pipeline to develop innovative solutions before, during and after a cancer diagnosis. Thermo Fisher Scientific boasts a $42.86

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Making a big impact in small patient populations

pharmaphorum

Approximately 85% of rare diseases are genetic, offering significant opportunities to develop better treatments as our understanding of the human genome improves 1. Concentrating on patient identification early in the clinical phases can drive brand loyalty and develop more effective tactics, to address unmet patient needs.

article thumbnail

Bayer to speed global development of vegetable seeds varieties at expanded R&D Center in Spain

The Pharma Data

The San Nicolás site supports Bayer’s global vegetable seeds R&D pipeline for varieties sold to customers in more than 130 countries and territories under the Seminis ® and De Ruiter ® brands, both united under Vegetables by Bayer. “By The Bayer brand stands for trust, reliability and quality throughout the world. billion euros.

article thumbnail

Build Connections with B2B Audiences through the Xtalks Life Science Podcast

XTalks

Life science podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the life science industry. The result?

article thumbnail

Latest analyses of Vitrakvi (larotrectinib) reaffirm powerful efficacy and tolerability profile for both adult and pediatric patients with TRK fusion cancer

The Pharma Data

These data reinforce the importance of early comprehensive genomic testing to uncover actionable oncogenic drivers, including NTRK gene fusions, to assist identify patients who are presumably to profit from a targeted treatment approach.”. The Bayer brand stands for trust, reliability and quality throughout the world. billion euros.

Gene 52
article thumbnail

Bayer to present latest research across its advancing oncology portfolio at AACR 2023 Annual Meeting

The Pharma Data

About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. The Bayer brand stands for trust, reliability and quality throughout the world. The company’s approach to research prioritizes targets and pathways with the potential to impact the way that cancer is treated.